Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer

NCT01547260 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Carcinoma Metastatic
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Gemzar
DRUG: Revlimid

Sponsor

Maria Liljefors

Collaborators

[object Object]
[object Object]
[object Object]